Author Capital Partners ("Author Capital" or "AuthorCap"), a Chicago-based principal investment firm, in partnership with ...
The availability of a four-in-one respiratory virus diagnostic for home use may be a boon to consumers, but some clinicians say it should not be used as a substitute for a physician’s guidance.
Research shows diagnostic labels legitimize suffering for some patients but can also increase stigma and anxiety when ...
Worried about your health? You can now avail yourself of noninvasive diagnostics that claim to screen for rare birth defects, cancer-associated mutations, and even Alzheimer’s. Even before the Covid ...
A car can be compared to the human body and may need diagnostic tests very often. For humans, when a patient consults a doctor about a symptom, the doctor runs a medical diagnostic test to ascertain ...
The diagnostics sector has benefited from a few trends in the past five years that not only have the potential to transform how we screen for cancer but also detect chronic conditions— such as ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. With a once-in-a-generation health emergency lifted, future ...
Roche is rolling out what it describes as a new type of infectious disease diagnostic in Europe, with a single test capable of screening for up to 12 of the most common respiratory viruses at once.
Many FDA-regulated companies are exploring ways to support diagnostic testing, especially when early diagnosis can impact treatment options. However, funding diagnostic testing tied to a company’s own ...
AMES, Iowa – A machine that holds more than 5,000 samples on a plate no wider than a couple of postage stamps is among the innovations that could vastly enhance molecular diagnostic testing capacity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results